SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing presentation: reset
Efficacy, Safety, and PK of BIC/FTC/TAF in Adults With HIV and Tuberculosis on Rifampicin at Week 24
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
1 of
1
|
Efficacy, Safety, and PK of BIC/FTC/TAF in Adults With HIV and Tuberculosis on Rifampicin at Week 24 (ABSTRACT
211)
Anushka Naidoo
Center for the AIDS Programme of Research in South Africa
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
1 of
1
|